J&J Spotlights FDA-Approved Surgical Robot Amid $100 Billion Revenue Push
Regulatory approval of a new Johnson & Johnson tool opens a new category in surgical robotics, the MedTech company said in a presentation released Tuesday (Oct. 13) in conjunction with its third-quarter earnings call. Johnson & Johnson’s new OTTAVA table-integrated soft tissue robotic system achieved U.S. Food and Drug Administration market authorization during the quarter. […] The post J&J…
We haven't written up this one. PYMNTS has the full story — the link below goes straight to it.
